81 Products from 5 Active Ingredient Categories Receive Revised Market Specifications

The Korea Food and Drug Administration (KFDA) recently announced that a total of 81 pharmaceutical products from 5 active ingredient categories have been issued the revised post-marketing approval specifications.

The items subject to the KFDA's revised specifications are 25 products of ciprofloxacin, 42 products of ciprofloxacin hydrochloride, 9 products of labetalol hydrochloride, 4 product...